Back to search

Virginia Commonwealth University

Therapy-Induced Senescence in Cancer: Developing Senolytic-Based Combination Strategies to Delay Re-emergence of Triple-Negative Breast Cancer

Abstract

dc:description.abstract

Therapy-induce senescence (TIS) represents a major biological outcome of many anticancer treatments and is increasingly recognized as a strategic vulnerability in triple negative breast cancer, which is a highly aggressive subtype with limited therapeutic options and frequent relapse. Here, we probed TIS as a primary cellular response that may ultimately compromise long-term outcomes using standard chemotherapeutic agents in TNBC as well as the antibody-drug conjugate sacituzumab govitecan (SG). Both chemotherapy and SG reliably induced pronounced senescence across TNBC models, yielding durable growth arrest, however, also generating a persistent reservoir of viable tumor cells capable of eventual proliferative recovery, a hallmark challenge of TIS. Senolytic treatments with ABT-263 (navitoclax) produced only a transient clearance of senescent cells across the treatments with doxorubicin, hydroxy-peroxy-cyclophosphamide, 5-FU, paclitaxel and gemcitabine. Platinum-based agents yielded senescent populations that appeared to be significantly more susceptible to sequential treatment combined with ABT-263. These findings indicate that whereas TIS can suppress the growth of tumors, it simultaneously creates a population of therapy-persisting cells that may fuel recurrence. Collectively, our data highlights TIS as a central, conserved treatment response across cytotoxic chemotherapy and also in an advanced targeted treatment approach, such as SG, which underscores the clinical challenge presented by senescent tumor cell survival. These studies further support the development of optimized senolytic combination strategies along with platinum compounds, potentially using safer Bcl-2/Bcl-xL inhibitors to enhance the clearance of TIS cells and improve long-term outcomes in TNBC.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Clinical and Translational Sciences

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chakraborty, Eesha
  • 0000-0003-3957-8064
Contributors dc:contributor
  • David Gewirtz
  • Hisashi Harada
  • Harry Bear
  • Larisa Litovchick
  • Lisa Shock

Subjects

dc:subject × 7

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Chakraborty, Eesha; 0000-0003-3957-8064. Therapy-Induced Senescence in Cancer: Developing Senolytic-Based Combination Strategies to Delay Re-emergence of Triple-Negative Breast Cancer. Dissertation thesis, https://doi.org/10.25772/REME-0W76